Leaderboards/dementia and cognitive impairment research

dementia and cognitive impairment research

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Ahmed Elazab
Shenzhen University
90
2
Hesam Aldin Varpaei
Michigan State University
70
3
Pari Mokhtari
Shariati Hospital
60
4
Ahmad R. Hariri
Duke University
40
5
Amanda Cano
Biomedical Research Networking Center on Neurodegenerative Diseases
30

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
John R. Sims
Eli Lilly (United States)
99
2
Nicolas R Barthélemy
Washington University in St. Louis
90
3
Rioghna R. Pittock
Mayo Clinic
50
4
Ethan T. Whitman
Duke University
50
5
Joaquim Raduà
Instituto de Salud Carlos III
40
6
Takashi Sakurai
National Center for Geriatrics and Gerontology
30
7
Mónika Fekete
Semmelweis University
20
8
Elisa Fabrizi
Universitat de València
10
9
Yuntao Chen
University College London
10

Emerging Leaders Papers

1
Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health
GeroScience|2025
20 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Miia Kivipelto
Stockholm University
99
2
Rik Ossenkoppele
Malmö University
99
3
Creighton H. Phelps
National Institute on Aging
90
4
Peritz Scheinberg
Beneficência Portuguesa de São Paulo
80
5
Nicholas J. Ashton
King's College London
80
6
Chunqi Chang
Shenzhen University
80
7
Oskar Hansson
Lund University
70
8
Reisa A. Sperling
Brigham and Women's Hospital
70
9
Karen H. Ashe
University of Minnesota
60
10
David B. Reuben
University of California, Los Angeles
60

All-Time Leaders Papers

1
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
Brain|2016
1.2k cit.
2
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
Nature Communications|2017
927 cit.
3
Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L)
Journal of Neuroscience|2005
716 cit.
4
Prevalence of Amyloid PET Positivity in Dementia Syndromes
JAMA|2015
663 cit.
5
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
Alzheimer s & Dementia|2022
568 cit.
6
fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease
Journal of Neurology Neurosurgery & Psychiatry|2002
456 cit.
7
Blood biomarkers for Alzheimer’s disease in clinical practice and trials
Nature Aging|2023
443 cit.
8
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease
JAMA Neurology|2021
305 cit.
9
Transgenic mice expressing a Huntington’s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
Proceedings of the National Academy of Sciences|1999
229 cit.
10
Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention
JAMA Neurology|2018
209 cit.

Reagents for dementia and cognitive impairment research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

Merlin/Ezrin/Radixin/Moesin (D1P8I) Rabbit Monoclonal Antibody

Cited in 5 papers
#23292$161
View Evidence →Cell Signaling Technology

Granzyme B (D2H2F) Rabbit Monoclonal Antibody (BSA and Azide Free)

#43701$865
View Evidence →Cell Signaling Technology

Cleaved Caspase-3 (Asp175) (5A1E) Rabbit Monoclonal Antibody (BSA and Azide Free)

#94530$898
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

ARH3 (E8A6G) Rabbit Monoclonal Antibody

Cited in 16 papers
#32205$175
View Evidence →Cell Signaling Technology

PA28 gamma Antibody

Cited in 13 papers
#2412$317
View Evidence →Cell Signaling Technology

GRB7 (E3W4G) Rabbit Monoclonal Antibody

Cited in 6 papers
#76518$161
View Evidence →